We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Bob is an analytical chemist with over 50 years’ experience, including 15 years working in the pharmaceutical industry and over 30 years working for the industry as a consultant.
The laboratory information management system (LIMS) landscape has evolved into a powerful ecosystem driving laboratory digitalization. From sample preparation to compliance reporting, enhanced informatics is reshaping workflows.
Yet integrating new tools such as AI, IoT, voice input or QR-coded tracking requires more than just plug-and-play. Laboratories must align digital upgrades with real business challenges, data integrity needs and staff readiness.
This listicle highlights practical ways to boost efficiency, minimize risk and enable real-time insights.
Download this listicle to explore:
How LIMS environments can transform sample prep, analysis and data reporting
The role of AI and IoT in reducing errors and streamlining decision-making
Practical guidance for evaluating tech maturity, governance and implementation risks
1
Listicle
The term LIMS typically refers to a software application. However, a better term is LIMS environment. This
broader concept not only encompasses the traditional LIMS functions such as sample management, data
management, results calculation and reporting, but also integration of analytical instruments and other
laboratory software systems, including instrument data systems, ELN (electronic lab notebooks) and LES
(lab execution systems).
The following listicle explores how innovative technology can increase process efficiency and support a
wider laboratory digitalization strategy.
The key to utilizing the technologies discussed in this listicle is to first understand and redesign lab processes
to work effectively electronically prior to implementation.
In addition, equally important is having a resilient, robust and fault-tolerant IT infrastructure. This includes
cybersecurity, adequate data storage, backup and recovery and responsive help desk support. Whether
hosted on-premises, in the cloud or a hybrid of both, this infrastructure is critical. This is essential because
as laboratories become more digitalized, any IT issue can quickly escalate to major disruptive incidents.
Caveat emptor!
Or in plain English: buyer beware. When it comes to adopting new technology, the laboratory and organization
are responsible for ensuring that the technology being purchased and implemented is truly fit for
its intended use.
It is easy to get excited about shiny new tools, especially with tech-savvy people in the lab or IT seeing
something cool and thinking: how can we use this? But that is often a case of technology in search of a
problem to solve.
Take the alternative view. What is your business problem? How can it be solved efficiently? What are the
options for implementation, at what cost and over what timeframe? How mature is your organization
when it comes to implementing and delivering IT projects? Are they typically on time and on budget?
Before diving into any of the innovations discussed here, you need a solid business case. Some solutions
are relatively simple; others are more complex. Either way, you must ensure that the business case is
Innovations in LIMS
for Enhanced Laboratory
Efficiency
Bob McDowall, PhD
INNOVATIONS IN LIMS FOR ENHANCED LABORATORY EFFICIENCY 2
Listicle
driving the adoption of innovative technologies and not vice versa. Bear this in mind as we discuss the
various innovations individually and how they can work to support your digital transformation.
QR-coded volumetric glassware
This is not the white heat of technology, but it is a simple and effective way to save time and reduce
errors in manual sample preparation. While laboratory automation often focuses on informatics, wet
chemistry and sample preparation remain a major element of analytical workflows. With smaller sample
volumes, it can be difficult to find cost-effective automation or robotics to implement.
The problem
When preparing a sample for instrumental analysis, many analytical procedures involve dissolving and
diluting a sample using volumetric glassware such as flasks and pipettes. Each item of grade A volumetric
glassware has a unique serial number etched on it. Analysts are expected to manually record these
numbers in the analytical batch record, which is a slow, tedious and error-prone process. And how do you
know the right glassware is being used for the right analysis?
The solution
To automate and streamline the process, volumetric glassware is now available with individual QR (quick
response) codes etched directly on each item. There are some options to affix QR-coded labels; however,
these must be durable and robust enough to resist laboratory use and washing/drying cycles for the life
of the flask. Etching, on the other hand, is permanent and wear resistant.
Here's how it works:
• Each item of glassware is registered in the LIMS application with key attributes such as:
◦ Type (e.g., pipette, flask)
◦ Size
◦ Grade (A or B)
◦ QR code identifier
• Sample preparation workflows can be set up and validated in the LIMS, ELN or LES, specifying the
required glassware.
• When a specific workflow is executed, each item of glassware used is scanned. The system checks
the item’s identity against the LIMS database and if incorrect, the analyst is prompted to select a
correct item. As only grade A glassware is permitted for pharmaceutical analysis, any use of grade B
glassware can be easily prevented.
This approach speeds up data entry, reduces errors and helps eliminate one potential source of
out-of-specification results. It also enables tracking of individual items of glassware across analyses,
providing a clear usage history.
The device used to scan the volumetric glassware can also be used to input other information about the
sample preparation, such as sample identities and contemporaneous documentation of any issues. We’ll
return to this topic later in this listicle to see how it fits into a fully integrated LIMS environment.
INNOVATIONS IN LIMS FOR ENHANCED LABORATORY EFFICIENCY 3
Listicle
Voice input (Alexa for the lab)
We are all aware of voice commands on smart speakers and mobile phones to handle some everyday
tasks. But what can be achieved in a laboratory?
The problem
Imagine you’re working in a fume cupboard and need to document what you’re doing. You’d have to stop,
remove your gloves, write down your observation, re-glove and carry on working? What a drag! Trying to
remember everything until you’ve finished or writing them on your lab coat sleeve or disposable glove
are not reliable or acceptable record-keeping options.
The solution
What you need is voice input, a way to capture observations in real time, hands-free. There are now apps
that support this and can be integrated with your LIMS.
Here’s how it works:
• An electronic workflow is established in the LIMS (or other informatics systems) to enforce the analytical
procedure.
• Voice and other input methods applicable for the procedure are linked to the workflow.
• The mobile devices for capturing inputs can be phones or tablets, but they should be company property,
not personal ones.
Voice input is not just used when encumbered with protective equipment but can also be used to record
manual tasks requiring observations that are currently documented on paper. And mobile devices can do
more than just capture voice, they can also take photos, scan barcodes or QR codes for identification of
samples, reference standards, instrument identities, QR-coded volumetric glassware, etc.
For example, tests based on observation or appearance could be automated by voice input along with a
picture of the sample. This not only speeds up initial testing but also makes second-person review faster
and more objective, thanks to the recorded evidence to confirm the observation.
However, voice input is not as easy as using a smart speaker at home, where any instruction from anyone
will be carried out. The system needs a vocabulary of laboratory terms so that it can understand the
context and meaning of the input. It also needs to be trained to recognize each user so that entries can be
properly attributed. This is where artificial intelligence (AI) comes in to help; it is used to analyze and train
the system and generate a voice profile for each user.
Internet of Things (IoT)
IoT is defined by the Food and Drug Administration (FDA) as:
A type of cyber-physical system comprising interconnected computing devices, sensors, instruments
and equipment integrated online into a cohesive network of devices that contain the hardware,
software, firmware and actuators which allow the devices to connect, interact and exchange data and
information. IoT devices include sensors, controllers and mechanical equipment.1
INNOVATIONS IN LIMS FOR ENHANCED LABORATORY EFFICIENCY 4
Listicle
Given the vagueness of the definition above, IoT can mean almost anything to anybody, depending on the
context.
The problem
Analytical processes are often complex, involving many subtasks and data points. Take a sample, for
example. You need to know:
• Storage conditions of each storage location (e.g., ambient, refrigerated, frozen or deep frozen)
• Whether those conditions are maintained correctly and are within limits
• How often a sample is taken out of storage and replaced (especially important for thermolabile samples)
• Knowing the position of the sample in its storage location, essential to aid quick retrieval and replacement
However, this is only one part of the analytical process; all tasks must be linked together for each analytical
procedure as a key step in the digitalization journey. That is where IoT helps.
The solution
Translating IoT for a laboratory environment involves a miscellany of analytical instruments,
instrument trays, displacement pipettes, volumetric glassware, samples, reference standards, buffers,
standard solutions, microtiter plates, vials for instrumental analysis and storage locations that are all
uniquely identified, usually by QR codes or barcodes. Even voice input can be included as part of the
LIMS environment.
The goal of IoT is to connect tasks across the analytical workflow to enable traceability, and it can be used
for:
1. Process verification, ensuring each step has been executed correctly and consistently
2. Faster analysis and second-person review, reducing delays and manual checks
3. Improved quality oversight with verified or validated workflow and traceable electronic records prior
to release
A few words of caution:
1. Cybersecurity can be a critical issue with some IoT devices. Before purchasing any device, assess
how security is set up, managed and maintained. Can default administrator credentials be changed
to protect the device and the laboratory data? Are communications protocols secure? Some devices
may be hardcoded with this information and cannot be changed – this is a red flag.
2. As mentioned earlier, is IoT a technology in search of a problem to solve? Or is there a business need
to meet? Ensure you have a strong business case.
If devices and instruments are used to acquire and transfer data, they need to be read and understandable.
One way to do this is analytical information markup language, a hypertext method of storing analytical
data using XML adapted for laboratories that includes compliance features. This is also important
when we consider the use of AI.
INNOVATIONS IN LIMS FOR ENHANCED LABORATORY EFFICIENCY 5
Listicle
Artificial intelligence and machine learning (AI / ML)
If not handled carefully, AI can become another innovation driven by hype and a search for a problem to
solve. AI has real potential in a LIMS environment. It’s important to distinguish between the two key types
of AI:
• Generative AI: This type of AI creates content based on training data. You must train the tool using
YOUR data rather than trawling the internet. This ensures you can set the boundaries of learning and
use. You will need two datasets: one for learning and another for independent testing. The learning is
only as good as the dataset used and directly affects the AI's performance.
• Adaptive AI: Once taught, this system continues to learn after development. While powerful, it presents
a challenge in regulated environments. How do you ensure it remains under control and does
not generate unreliable outputs or hallucinations? Our recommended approach is to maintain two
versions of the released and tested system:
◦ A live version that operates without self-learning so that it remains under control.
◦ A shadow version that is not operational but can self-learn from the additional data inputs to
the first version. The shadow version can be tested using the updated test dataset and released
for operational use if it performs well. The first operative version would be retired, and
the cycle repeated.
To manage this responsibility, organizations need AI governance to oversee how generative AI is used.2
The problem:
Where can AI deliver business value?
One major area is data collation and trending. The current focus is on testing versus specification release.
At the end of a year, an annual product review/product quality review must be conducted in pharma.
3, 4 Typically, these involve the collation of test results from all batches, usually by generating spreadsheets
and manually performing trend evaluation. This is a slow, tedious and time-consuming task.
The solution:
AI can help laboratories change from a reactive to a proactive approach.
Instead of waiting until year-end to review trends and respond to issues, AI can be trained to continuously
monitor batch data as it’s released. Indeed, why limit the review to just a year? An ongoing review could
be performed over a longer period if required.
The benefits would include:
• Predictive analytics that spot trends early
• Faster, more consistent detection of potential issues
• Quicker identification of problems before they escalate
The FDA has recently published a draft guidance on using AI for regulatory decision-making. It emphasizes
the credibility of the AI, not just validation and introduces the concept of context of use to define how AI
should be applied.5
INNOVATIONS IN LIMS FOR ENHANCED LABORATORY EFFICIENCY 6
Listicle
To make AI work effectively, you will need:
• High-quality, well-structured data for training and testing
• Clearly defined use cases
• Sufficient computing power for the AI models to work effectively
Bringing it all together
In this listicle, we have explored four innovations that can enhance a LIMS environment. Each one offers
a targeted solution to a specific business challenge. Think of them as pieces of a laboratory jigsaw puzzle,
each of which can contribute to the broader goal of automation and digitalization of a laboratory. Figure 1
illustrates how they could all be integrated to leverage major process improvements in a laboratory.
Figure 1. Integration of innovations in a LIMS environment to enhance laboratory efficiency. Credit: Bob McDowall.
Artical Intelligence/
Machine Learning:
Trending Data
Sample
Registration
Laboratory
Information
Management System
Sample Receipt
and Storage
Locations
Instrumental
Analysis
• Samples coded
• Sample storage
cabinets coded
• Individual
locations in
cabinet coded
• Check in of
samples
• Check out of
samples
• Monitoring of
storage
conditions
(temperatute
& RH as needed)
• Return of
samples for
check in —
storage location
updated
Interpretation/
Calculation of
Results
• SST samples
interpreted and
checked versus
acceptance
criteria
• Standards and
QCs interpreted
and checked
• Samples
interpreted
and checked
• Results of
aliquots
calculated
• Calculate
reportable result
• Transfer of the
results to LIMS
for collation
Collaion and
Reporting Results
• Results from all
tests collated
for the sample
• Check for Out of
Specification
results
• Resolve any
issues or
deviations
• Issue electronic
CoA
• Identify
instrument to use
and check status
• Is it the right
instrument?
• Unique user
identity to set up
instrument
• Point of use
check/System
Suitability Test
• Transfer vials to
autosampler
• Bottom of vial
uniquely
numbered and
linked to
injection
sequence
• Each vial
scanned when
injected and
linked to sample
identity: no vial
mix ups possible
Sample
Preparation
• Colour and
observation tests
captured
electronically
(results sent to
LIMS from here)
• Standards,
solutions,
reagents and
buffers coded
• Solutions
prepared fresh
coded
• QR coded
glassware
• Balances and pH
meters on line to
LIMS or
Instrument data
system
• Analytical data
captured
electronically
or by voice
input
• Extracts are
transferred to QR
coded vials
• Chain of custody
for preparation
work
On-going
Product/Annual Quality
Reviews
Electronic
Analysis (CoA)
INNOVATIONS IN LIMS FOR ENHANCED LABORATORY EFFICIENCY 7
Listicle
Organizational maturity and staff training
We can discuss many kinds of innovations to boost laboratory productivity, but how ready is your organization
to implement them?
An organization’s technological maturity plays a crucial role, and it should consider the following:
• Are automation projects delivered on time and within budget, or are they hopelessly late and become
a money pit?
• How are staff involved in these projects? Are they engaged and motivated, with a sense of ownership?
• Do analysts have the skills, incentive and experience to implement and use new technologies effectively?
• How well are analysts trained to use the new ways of working? There needs to be a clear pathway
from the current to the new ways of working. Roles will evolve as these systems do not come with a
simple “ON” button; they still require staff to set up, operate and manage them.
You might have cutting-edge innovative technology, but you also need the trained and motivated analytical
staff to use it to your advantage and unlock its full potential.
Acknowledgements
I thank Gemma Harben and Joost Van Kempen for their help in reviewing and preparing this listicle.
References
1. Food and Drug Administration. Artificial Intelligence in Drug Manufacturing. Silver Spring, MD: Food and Drug Administration;
2023.
2. Mintanciyan A, Budihandojo R, English J, Lopez O, Matos JE, McDowall R, Artificial Intelligence Governance in GXP Environments.
Pharm Eng. 2024;44(4):62-67.
3. Food and Drug Administration. 21 CFR 211 Current Good Manufacturing Practice for Finished Pharmaceutical Products.
Silver Spring, MD: Food and Drug Administration; 2008.
4. European Commission. EudraLex - Volume 4 Good Manufacturing Practice (GMP) Guidelines, Chapter 1 Pharmaceutical Quality
System. Brussels: European Commission; 2013.
5. Food and Drug Administration. FDA Draft Guidance for Industry Considerations for the Use of Artificial Intelligence to Support
Regulatory Decision-Making for Drug and Biological Products. Silver Spring, MD: Food and Drug Administration; 2025.
About the Author:
Bob McDowall is an analytical chemist who has been involved with specifying laboratory informatics solutions for over 40
years and has nearly 35 years’ experience of computerized system validation in regulated GXP environments.
Download the List for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.